• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化 CYP2E1 抑制的化学特性。

Chemical characteristics for optimizing CYP2E1 inhibition.

机构信息

Department of Toxicology, P.O. Box 616, 6200 MD, Maastricht, Maastricht University, The Netherlands.

Department of Toxicology, P.O. Box 616, 6200 MD, Maastricht, Maastricht University, The Netherlands.

出版信息

Chem Biol Interact. 2015 Dec 5;242:139-44. doi: 10.1016/j.cbi.2015.09.024. Epub 2015 Sep 30.

DOI:10.1016/j.cbi.2015.09.024
PMID:26428356
Abstract

Cytochrome P450 2E1 (CYP2E1) expression and activity in the liver is associated with the degree of liver damage in patients with alcoholic steatohepatitis (ASH) as well as non-alcoholic steatohepatitis (NASH). CYP2E1 is known to generate reactive oxygen species, which leads to oxidative stress, one of the hallmarks of both diseases. Apart from ROS, toxic metabolites can be formed by CYP2E1 metabolism, further potentiating liver injury. Therefore, CYP2E1 is implicated in the pathogenesis of ASH and NASH. The aim of this study was to determine the chemical characteristics of compounds that are important to inhibit CYP2E1. To this end, structurally related analogs that differed in their lipophilic, steric and electronic properties were tested. In addition, homologues series of aliphatic primary alcohols, secondary alcohols, aldehydes, ketones and carboxylic acids were tested. It was found that inhibition of the CYP2E1 activity is primarily governed by lipophilicity. The optimal log D7.4 (octanol/water distribution coefficient at pH 7.4) value for inhibition of CYP2E1 was approximately 2.4. In the carboxylic acids series the interaction of the carboxylate group with polar residues lining the CYP2E1 active site also has to be considered. This study sketches the basic prerequisites in the search for inhibitors of CYP2E1, which would strengthen our therapeutic armamentarium against CYP2E1 associated diseases, such as ASH and NASH.

摘要

细胞色素 P450 2E1(CYP2E1)在肝脏中的表达和活性与酒精性脂肪性肝炎(ASH)和非酒精性脂肪性肝炎(NASH)患者的肝损伤程度有关。众所周知,CYP2E1 会产生活性氧,从而导致氧化应激,这是这两种疾病的特征之一。除了 ROS 之外,CYP2E1 代谢还可以形成有毒代谢物,进一步加剧肝损伤。因此,CYP2E1 与 ASH 和 NASH 的发病机制有关。本研究旨在确定对抑制 CYP2E1 很重要的化合物的化学特性。为此,测试了在亲脂性、立体和电子性质上有所不同的结构相关类似物。此外,还测试了脂肪族伯醇、仲醇、醛、酮和羧酸的同系物系列。结果发现,CYP2E1 活性的抑制主要受亲脂性控制。抑制 CYP2E1 的最佳 log D7.4(pH 7.4 时的辛醇/水分配系数)值约为 2.4。在羧酸系列中,还必须考虑羧酸基团与排列在 CYP2E1 活性部位的极性残基的相互作用。这项研究概述了寻找 CYP2E1 抑制剂的基本前提条件,这将增强我们对抗 CYP2E1 相关疾病(如 ASH 和 NASH)的治疗手段。

相似文献

1
Chemical characteristics for optimizing CYP2E1 inhibition.优化 CYP2E1 抑制的化学特性。
Chem Biol Interact. 2015 Dec 5;242:139-44. doi: 10.1016/j.cbi.2015.09.024. Epub 2015 Sep 30.
2
An improved in vitro method for screening toxin and medicine targeting CYP2E1.一种改进的用于筛选靶向CYP2E1的毒素和药物的体外方法。
Environ Toxicol Pharmacol. 2016 Oct;47:86-91. doi: 10.1016/j.etap.2016.09.006. Epub 2016 Sep 14.
3
Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH).吡格列酮、槲皮素和羟基柠檬酸对实验性诱导的非酒精性脂肪性肝炎(NASH)中细胞色素P450 2E1(CYP2E1)酶水平的影响。
Eur Rev Med Pharmacol Sci. 2014;18(18):2736-41.
4
The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role.微粒体乙醇氧化系统的发现及其生理和病理作用。
Drug Metab Rev. 2004 Oct;36(3-4):511-29. doi: 10.1081/dmr-200033441.
5
The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts.活性氧(ROS)和细胞色素P-450 2E1在致癌性乙烯基-DNA加合物生成中的作用。
Redox Biol. 2014;3:56-62. doi: 10.1016/j.redox.2014.08.009. Epub 2014 Sep 6.
6
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者肝脏中的细胞色素P450 2E1水平升高。
Hepatology. 1998 Jan;27(1):128-33. doi: 10.1002/hep.510270121.
7
Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.靶向 CYP2E1 的药物治疗早期酒精性脂肪性肝炎。
PLoS One. 2020 Jul 23;15(7):e0235990. doi: 10.1371/journal.pone.0235990. eCollection 2020.
8
Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role.非酒精性脂肪性肝病中细胞色素 P450 2E1 的表达增加:机制和病理生理作用。
Clin Res Hepatol Gastroenterol. 2011 Oct;35(10):630-7. doi: 10.1016/j.clinre.2011.04.015. Epub 2011 Jun 12.
9
Translational Implications of the Alcohol-Metabolizing Enzymes, Including Cytochrome P450-2E1, in Alcoholic and Nonalcoholic Liver Disease.酒精代谢酶(包括细胞色素P450-2E1)在酒精性和非酒精性肝病中的转化意义。
Adv Pharmacol. 2015;74:303-72. doi: 10.1016/bs.apha.2015.04.002. Epub 2015 Jun 27.
10
Inhibition of CYP2E1 leads to decreased advanced glycated end product formation in high glucose treated ADH and CYP2E1 over-expressing VL-17A cells.在高糖处理的ADH和CYP2E1过表达的VL-17A细胞中,抑制CYP2E1可导致晚期糖基化终产物形成减少。
Biochim Biophys Acta. 2013 Oct;1830(10):4407-16. doi: 10.1016/j.bbagen.2013.05.022. Epub 2013 May 23.